A61P 1/08

Sub-Class

Watch

Stats

Description

Class  A61P : THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS


Subclass 1/08: Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
10435445 Peptide compoundMar 30, 18Oct 08, 19Takeda Pharmaceutical Company Limited
10399949 NK1 receptor antagonistDec 06, 16Sep 03, 19Kissei Pharmaceutical Co., Ltd,
10377711 Cannabinoid type 1 receptor modulatorsAug 26, 15Aug 13, 19The University Court of the University of Aberdeen; The Governing Council of the University of Toronto;
10357570 Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronFeb 14, 18Jul 23, 19Heron Therapeutics, Inc.
10335398 Bioadhesive compositions for intranasal administration of granisetronApr 08, 15Jul 02, 19MAXINASE LIFE SCIENCES LIMITED
10278996 Bee-ingestible compositions, methods of using same for producing honey and honey produced therebyJan 22, 18May 07, 19Phytopharma International Ltd.
10189848 Ethynyl derivativesJan 12, 18Jan 29, 19Hoffmann-La Roche, Inc.
9913910 Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetronSep 19, 16Mar 13, 18HERON THERAPEUTICS, INC.
9675588 Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptomsMar 11, 15Jun 13, 17REDHILL BIOPHARMA LTD.
9439920 Composition for the management of nausea and vomitingOct 03, 14Sep 13, 16DUCHESNAY INC.
9265724 Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein deliverySep 07, 10Feb 23, 16Not available
9227958 Amorphous and crystalline forms of aprepitant and processes for the preparation thereofFeb 02, 07Jan 05, 16GLENMARK PHARMACEUTICALS LIMITED
9066886 Transdermal drug delivery system containing granisetronAug 22, 08Jun 30, 15TAHO PHARMACEUTICALS LTD.
9066887 Transdermal therapeutic system having urea componentsDec 09, 08Jun 30, 15LTS LOHMANN THERAPIE-SYSTEME AG
9051273 Phosphodiesterase 4 inhibitor capable of avoiding vomitingAug 25, 12Jun 09, 15GUANGZHOU LANSSON PHARMACEUTICAL CO., LTD.
8901111 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolaseJun 04, 10Dec 02, 14JANSSEN PHARMACEUTICA NV
8795634 Absorption of therapeutic agents across mucosal membranes or the skinSep 14, 09Aug 05, 14CRITICAL PHARMACEUTICALS LIMITED
8653063 N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activityJan 22, 10Feb 18, 14ASKAT INC.
8623826 Compositions and methods for treating centrally mediated nausea and vomitingMar 31, 11Jan 07, 14HELSINN HEALTHCARE SA
8372883 Methods of using cycloalkylmethylaminesJul 05, 11Feb 12, 13Reviva Pharmaceuticals, Inc.

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2018/0155,344 TRICYCLIC PIPERIDINE COMPOUNDSMay 03, 16Jun 07, 18Actelion Pharmaceuticals Ltd.
2013/0065,885 ORAL THERAPEUTIC COMPOUND DELIVERY SYSTEMSep 14, 12Mar 14, 13JOHNSON & JOHNSON CONSUMER INC., IMAGINOT PTY LTD.,
2013/0058,981 Combination pharmaceutical compositions and method of treatment of vertigo, kinetosis and vegetative-vascular dystoniaJul 15, 11Mar 07, 13Not available
2012/0046,279 Oligomer-Phenothiazine ConjugatesJan 28, 10Feb 23, 12NEKTAR THERAPEUTICS
2011/0251,233 FORMULATION FOR THE BUCCAL TRANSMUCOSAL ADMINISTRATION OF SETRONSDec 17, 09Oct 13, 11Not available
2010/0249,165 PDZ DOMAIN MODULATORSJun 03, 08Sep 30, 10NEUROSEARCH A/S, UNIVERSITY OF COPENHAGEN,

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance